Chaga: the birch charcoal that concentrates centuries of boreal forest

Some fungi fruit in a single night; others take a lifetime. Chaga (Inonotus obliquus) belongs to the latter lineage: it grows for fifteen or twenty years as a black, cracked mass on the trunks of birch trees in the boreal forests of Siberia, Scandinavia, Canada, and northern Asia. What looks like charcoal fused to the bark is in fact a sclerotium — a hardened fungal tissue that absorbs and transforms the compounds of the host birch over decades. That slowness has a chemical purpose: Chaga concentrates a density of metabolites that few organisms can match.

Main Active Compounds

  • Polysaccharides, especially β-glucans and the so-called IOP (Inonotus obliquus polysaccharides), associated with immunomodulatory and antioxidant activity.
  • Melanins, the pigments responsible for its characteristic black color, with antioxidant capacity and a bifidogenic effect on the microbiota.
  • Lanostane-type triterpenoids, among them inotodiol, and betulinic-acid derivatives that the fungus absorbs from the birch.
  • Polyphenols and phenolic compounds that contribute to its high capacity to neutralize free radicals.

Scientifically Documented Effects

Antioxidant Capacity

Polysaccharides isolated from Chaga have shown notable free-radical scavenging activity in experimental models, a mechanism that helps maintain balance against cellular oxidative stress. The fungus's melanins have also been studied for their antioxidant potential and their favorable interaction with intestinal bacteria.

Immune Response Modulation

Research on Chaga polysaccharides describes their ability to modulate the activity of immune cells through signaling pathways such as NF-κB and MAPK, supporting scientific interest in this fungus as a modulator — not an indiscriminate stimulant — of the immune system.

Therapeutic Profile Under Review

Recent reviews compile the research on its antioxidant and immunomodulatory properties and its singular chemical composition, while noting that much of the evidence comes from preclinical studies and that rigorous clinical trials in humans are still required.

How to Take It

Traditionally, Chaga is prepared as an infusion or a prolonged decoction, since its compounds need time and heat to be drawn from the hardened tissue. It is also taken as concentrated extracts and as powder. Given its density of compounds, it is best to begin with moderate amounts.

Precautions

Chaga contains oxalates, so people with a history of kidney stones should consult a health professional before taking it. It may interact with anticoagulants and with diabetes medications. It is not recommended during pregnancy or breastfeeding without medical supervision.

This content is for informational and educational purposes only. It does not replace medical consultation. Simbiosis products do not cure, treat, or prevent any disease; they contribute to supporting well-being within a healthy lifestyle.

References

  • Ern PTY, Quan TY, Yee FS, Yin ACY. Therapeutic properties of Inonotus obliquus (Chaga mushroom): A review. Mycology. 2023;15(2):144-161. PMID: 38813471. DOI: 10.1080/21501203.2023.2260408
  • Hu Y, Sheng Y, Yu M, et al. Antioxidant activity of Inonotus obliquus polysaccharide and its amelioration for chronic pancreatitis in mice. Int J Biol Macromol. 2016;87:348-56. PMID: 26955745. DOI: 10.1016/j.ijbiomac.2016.03.006
  • Burmasova MA, Utebaeva AA, Sysoeva EV, Sysoeva MA. Melanins of Inonotus obliquus: Bifidogenic and Antioxidant Properties. Biomolecules. 2019;9(6):248. PMID: 31238558. DOI: 10.3390/biom9060248
  • Sang R, Sun F, Zhou H, et al. Immunomodulatory effects of Inonotus obliquus polysaccharide on splenic lymphocytes infected with Toxoplasma gondii via NF-κB and MAPKs pathways. Immunopharmacol Immunotoxicol. 2021;44(1):129-138. PMID: 34918603. DOI: 10.1080/08923973.2021.2017453